ArticleMaterials today. Bio2026
Modulating cell surface chemistry through mild reduction reinforces extracellular-to-intracellular transmission forces and mechano-signaling.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell surface engineering offers a powerful strategy to modulate cellular behaviors, including adhesion, migration, and differentiation. While cell fate is typically governed by extracellular cues such as matrix ligands, engineered cell surfaces can reshape how these signals are sensed and transduced. Here, we present a facile and robust approach to cell surface engineering via mild chemical reduction. Using tris(2-carboxyethyl)phosphine (TCEP), a gentle reducing agent, we modulated surface-exposed disulfide bonds to induce adhesion-dependent signaling without genetic manipulation. This strategy was applied to preadipocytes to investigate its effects on cell adhesion, mechanotransduction, and adipogenic differentiation. Mild surface reduction induced pronounced morphological changes, including increased spreading, elongation, and cytoskeletal reorganization. Notably, TCEP treatment enhanced focal adhesion kinase (FAK)-associated adhesion and mechanotransductive signaling, accompanied by elevated cell-matrix traction forces, increased intracellular tension, and enhanced cytoskeletal-nuclear force transmission. These multiscale mechanical responses were quantified using traction force microscopy, intracellular force microscopy, and nuclear envelope wrinkling analysis. Functionally, these coordinated mechanobiological changes suppressed adipogenic differentiation, even under adipogenic induction conditions. Taken together, our findings demonstrate that mild chemical reduction of the cell surface modulates adhesion-dependent mechanotransduction through a FAK-centered force-transmission pathway, reinforcing cytoskeletal and nuclear mechanics to inhibit adipogenesis. This work highlights surface redox modulation as a non-genetic strategy to regulate cellular mechanics and lineage commitment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.